Tokyo Tape
Sign in
← Carna Biosciences

Quarterly report · Q1

4572.TEDINET S100QP76
Period2023-01-01 → 2023-03-31
Filed2023-05-11
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥227m2023-01-01 → 2023-03-31Cons.Net sales
Revenue¥1.4bn2022-01-01 → 2022-12-31Cons.Net sales (5-year summary)
Revenue¥555m2022-01-01 → 2022-03-31Cons.Net sales
Operating income−¥506m2023-01-01 → 2023-03-31Cons.Operating income
Operating income¥1m2022-01-01 → 2022-03-31Cons.Operating income
Ordinary income−¥513m2023-01-01 → 2023-03-31Cons.Ordinary income
Ordinary income−¥1.3bn2022-01-01 → 2022-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥5m2022-01-01 → 2022-03-31Cons.Ordinary income
Profit before tax−¥514m2023-01-01 → 2023-03-31Cons.Income before income taxes
Profit before tax−¥11m2022-01-01 → 2022-03-31Cons.Income before income taxes
Net income (owners)−¥519m2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥1.3bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥15m2022-01-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income−¥519m2023-01-01 → 2023-03-31Cons.Profit loss
Net income−¥15m2022-01-01 → 2022-03-31Cons.Profit loss
Total assets¥4.9bnat 2023-03-31Cons.Assets
Total assets¥4.3bnat 2022-12-31Cons.Assets
Total assets¥5.4bnat 2022-03-31Cons.Total assets (5-year summary)
Total liabilities¥547mat 2023-03-31Cons.Liabilities
Total liabilities¥625mat 2022-12-31Cons.Liabilities
Net assets / equity¥4.4bnat 2023-03-31Cons.Net assets
Net assets / equity¥3.6bnat 2022-12-31Cons.Net assets
Net assets / equity¥4.5bnat 2022-03-31Cons.Net assets (5-year summary)
Cash and deposits¥4.1bnat 2023-03-31Cons.Cash and deposits
Cash and deposits¥3.4bnat 2022-12-31Cons.Cash and deposits
EPS (basic)¥-32.782023-01-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-99.12022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-1.122022-01-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio88.8%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio85.0%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio84.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
jpcrp040300-q1r_E00987-000Drug Discovery Businessreportable segmentsegment profit2023-01-01 → 2023-03-31−¥570m
jpcrp040300-q1r_E00987-000Drug Discovery Support Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥227m
jpcrp040300-q1r_E00987-000Drug Discovery Support Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥227m
jpcrp040300-q1r_E00987-000Drug Discovery Support Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥64m
jpcrp040300-q1r_E00987-000Drug Discovery Businessreportable segmentrevenue2022-01-01 → 2022-03-31¥286m
jpcrp040300-q1r_E00987-000Drug Discovery Businessreportable segmentrevenue external2022-01-01 → 2022-03-31¥286m
jpcrp040300-q1r_E00987-000Drug Discovery Businessreportable segmentsegment profit2022-01-01 → 2022-03-31−¥108m
jpcrp040300-q1r_E00987-000Drug Discovery Support Businessreportable segmentrevenue2022-01-01 → 2022-03-31¥269m
jpcrp040300-q1r_E00987-000Drug Discovery Support Businessreportable segmentrevenue external2022-01-01 → 2022-03-31¥269m
jpcrp040300-q1r_E00987-000Drug Discovery Support Businessreportable segmentsegment profit2022-01-01 → 2022-03-31¥109m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 304
ItemContextValueUnit
LiabilitiesPrior1YearInstant624609000JPY
LiabilitiesCurrentQuarterInstant547420000JPY
Capital stockPrior1YearInstant1382246000JPY
Capital stockCurrentQuarterInstant2023976000JPY
Capital surplusPrior1YearInstant5133456000JPY
Capital surplusCurrentQuarterInstant5775186000JPY
Retained earningsPrior1YearInstant-2922490000JPY
Retained earningsCurrentQuarterInstant-3441701000JPY
Treasury stockPrior1YearInstant-222000JPY
Treasury stockCurrentQuarterInstant-222000JPY
Shareholders equityPrior1YearInstant3592988000JPY
Shareholders equityCurrentQuarterInstant4357238000JPY
Valuation difference on available for sale securitiesPrior1YearInstant-2373000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant-2474000JPY
Deferred gains or losses on hedgesPrior1YearInstant615000JPY
Deferred gains or losses on hedgesCurrentQuarterInstant－JPY
Foreign currency translation adjustmentPrior1YearInstant33225000JPY
Foreign currency translation adjustmentCurrentQuarterInstant34874000JPY
Valuation and translation adjustmentsPrior1YearInstant31467000JPY
Valuation and translation adjustmentsCurrentQuarterInstant32400000JPY
Subscription rights to sharesPrior1YearInstant17388000JPY
Subscription rights to sharesCurrentQuarterInstant8202000JPY
Net assetsPrior1YearInstant3641844000JPY
Net assetsCurrentQuarterInstant4397841000JPY
Liabilities and net assetsPrior1YearInstant4266453000JPY
Liabilities and net assetsCurrentQuarterInstant4945261000JPY
Net salesPrior1YTDDuration554650000JPY
Net salesCurrentYTDDuration226967000JPY
Cost of salesPrior1YTDDuration42483000JPY
Cost of salesCurrentYTDDuration48635000JPY
Gross profitPrior1YTDDuration512167000JPY
Gross profitCurrentYTDDuration178332000JPY
Selling general and administrative expensesPrior1YTDDuration511032000JPY
Selling general and administrative expensesCurrentYTDDuration684125000JPY
Operating incomePrior1YTDDuration1135000JPY
Operating incomeCurrentYTDDuration-505792000JPY
Interest income noiPrior1YTDDuration44000JPY
Interest income noiCurrentYTDDuration64000JPY
Dividends income noiPrior1YTDDuration101000JPY
Dividends income noiCurrentYTDDuration105000JPY
Insurance income noiPrior1YTDDuration1906000JPY
Insurance income noiCurrentYTDDuration－JPY
Foreign exchange gains noiPrior1YTDDuration3493000JPY
Foreign exchange gains noiCurrentYTDDuration－JPY
Other noiPrior1YTDDuration398000JPY
Other noiCurrentYTDDuration23000JPY
Non operating incomePrior1YTDDuration5944000JPY
Non operating incomeCurrentYTDDuration193000JPY
Interest expenses noePrior1YTDDuration1634000JPY
Interest expenses noeCurrentYTDDuration896000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass